Details 3 Related Guidelines / Approvals

Indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.

type

FDA Approval

approval date

2017-11-06

settings
settings
Metastatic
source

FDA